BioCardia
BCDA
18 hedge funds and large institutions have $552K invested in BioCardia in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 3 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
13% more funds holding
Funds holding: 16 → 18 (+2)
1.47% more ownership
Funds ownership: 5.88% → 7.35% (+1.5%)
7% less capital invested
Capital invested by funds: $593K → $552K (-$41.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$163K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$37.8K |
| 3 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$33.2K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$31.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$12.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$39.5K |
| 2 |
Raymond James Financial
St Petersburg,
Florida
|
-$3.58K |
| 3 |
JP Morgan Chase
New York
|
-$456 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2 |
BCDA Hedge Fund Activity: Q3 2025 in Review
18 of the 7,637 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q3 2025, worth a combined $552K — down 7% from $593K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BCDA positions and 3 closed out — a net gain of 2 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, adding an estimated $163K. The largest seller was Cetera Investment Advisers, exiting entirely with an estimated $39.5K sold.
- 18 institutional investors held BioCardia (BCDA) as of Q3 2025, up from 16 in Q2 2025.
- Funds reported $552K of BioCardia stock for Q3 2025, down 7% quarter-over-quarter.
- 5 funds opened new BioCardia positions in Q3 2025 and 3 closed out, a net change of +2 holders.
- The largest BioCardia buyer in Q3 2025 was Vanguard Group, an estimated $163K added.
- The largest BioCardia seller in Q3 2025 was Cetera Investment Advisers, an estimated $39.5K sold.
Based on aggregated 13F filings for Q3 2025.